Developer docs
API playgroundTry for free, no card

Search company profiles

Freyr Solutions

Full company profile

uuid0006qk9

Namestring
Freyr Solutions
Legal namestring
Freyr Solutions
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Freyr Solutions is a global regulatory solutions and services company founded in 2011 and headquartered in Princeton, USA, with its primary operational hub in Hyderabad, India. The company serves pharmaceutical, medical device, and consumer product companies across 120+ countries, employing 2,500+ in-house regulatory experts and operating through a network of 850+ in-country regulatory affiliates, 20+ global operational centers, and 10 global delivery hubs. Its core offering is Freya Fusion, an AI-first regulatory cloud platform covering the full regulatory information management (RIM) lifecycle — registrations, submissions, labeling, artwork, intelligence, and change control — complemented by specialized AI products including Freya Intelligence (a regulatory-context-trained knowledge retrieval wizard), Via (an autonomous variation identification agent), and Freyr GRI (an AI/NLP/ML-powered global regulatory intelligence platform).

The company's revenue model combines professional services — regulatory affairs strategy, submissions management, pharmacovigilance, regulatory medical writing, and quality/compliance auditing — with subscription-based SaaS offerings on the Freya Fusion platform. Services are sold via direct enterprise sales to large pharmaceutical, medical device, and consumer product manufacturers under multi-year, quote-based contracts. Customer segments are organized vertically, with pharmaceutical/medicinal products and medical device manufacturers as primary, and cosmetics, food/dietary supplements, and chemical products as secondary verticals. Go-to-market is enterprise-led, supported by inside sales and content marketing (whitepapers, webinars, podcasts, and case studies).

In 2024, Freyr was recognized by Everest Group as a Leader in its PEAK Matrix Assessment for Life Sciences Regulatory and Medical Affairs Operations. The company maintains named executive leadership including Co-Founder and Co-CEO Rajiv Rangan, Co-Founder and Chief Risk Officer Srinivas Ranabothu, Co-Founder Srini Sadhu, and CTO Praveen Bezawada. Ownership is private with no disclosed parent, investor, or funding history in the source material.

Short descriptiontext

Freyr Solutions is a global regulatory solutions and services provider serving pharmaceutical, medical device, and consumer product companies across 120+ countries with 2,500+ in-house experts and an AI-first regulatory cloud platform (Freya Fusion) covering submissions, labeling, and lifecycle management.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersPrinceton, United States
HQ citystring
Princeton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory affairs services, pharmacovigilance services, medical device compliance, regulatory cloud platform, global regulatory intelligence
Industry1 code
PRIMARYHLAAADAJ
RNA Therapeutics Regulatory, Quality & Pharmacovigilance (GxP, comparability, post-market)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)
NAICS code1 code
  • Management, Scientific, and Technical Consulting Services5416
SIC code1 code
  • Services-Engineering, Accounting, Research, Management8700
Product category
Life Sciences Regulatory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Regulatory Affairs Services
TypeProfessional Services
Description

End-to-end regulatory affairs consulting and support including regulatory strategy, submissions management, dossier authoring, and lifecycle management for pharmaceutical, medical device, and consumer product companies.

freyrsolutions.com
2Pharmacovigilance Services
TypeProfessional Services
Description

Drug safety monitoring services including medical literature monitoring, individual case safety reports, aggregate safety reports, signal detection, and risk management plans.

freyrsolutions.com
3Quality Management and Compliance Services
TypeProfessional Services
Description

QMS consultancy, GxP audit services, CSV/CSA services, SOP writing, and regulatory compliance validation for medical devices and pharmaceutical companies.

freyrsolutions.com
4Regulatory Technology Solutions
TypeSubscription Recurring
Description

SaaS-based regulatory cloud platform (Freya Fusion) with AI capabilities for submissions management, labeling management, regulatory intelligence, and change control.

freyrsolutions.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom enterprise pricing based on project scope
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing; no public pricing tiers available. Services are tailored to client requirements with pricing dependent on regulatory complexity, number of markets, product types, and engagement model (FSP, RAaaS, full outsourcing).

freyrsolutions.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Freya Fusion
Description

AI-First Regulatory Cloud - unified regulatory platform designed to manage entire regulatory lifecycle and be the single source of truth for data. Streamlines processes, ensures compliance, and accelerates time-to-market with intelligent automation and connected workflows.

freyrsolutions.com
+3 more records
Core offering1 text field

Freyr Solutions delivers end-to-end regulatory solutions and services for pharmaceutical, medical device, and consumer product companies across 120+ countries. The core offering combines professional services (regulatory affairs, regulatory operations, medical writing, pharmacovigilance, quality/compliance, artwork) with the AI-first Freya Fusion regulatory cloud platform covering RIM, submissions, labeling, artwork, intelligence, and change control. Freyr supports large, medium, and small life sciences firms with 2,500+ in-house regulatory experts and localized affiliate support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Zero rejections achieved for pharmaceutical company managing 15+ ANDAs/NDAs
+2 more records
Product overview1 text field

Freyr Solutions is the largest global Regulatory solutions and services provider offering end-to-end solutions to the Pharmaceutical (Medicinal Products), Medical Devices, and Consumer sectors. The portfolio consists of the core AI-first technology platform Freya Fusion (unified regulatory cloud covering RIM, submissions, labeling, artwork, intelligence, and change control) supported by specialized sub-products including Freya Intelligence (AI-enabled regulatory advisor with knowledge retrieval), Via (Variation Identification Agent for autonomous post-approval change management), and Freyr GRI (AI/NLP/ML-powered global regulatory intelligence). Services span Regulatory Affairs, Regulatory Operations, Regulatory Medical Writing, Pharmacovigilance, Quality Management, Medical Writing for Medical Devices, Performance Evaluation (IVD), Literature Search Protocol, and Compliance/Audit services across 120+ countries.

Product and service6 records
1Freya Fusion
CategoryRegulatory Cloud Platform / Regulatory Information Management (RIM) Software
Description

Freya Fusion is an AI-first regulatory cloud platform built on 15+ years of regulatory expertise and advanced AI/ML capabilities. It serves as a unified ecosystem for RIM (Regulatory Information Management), providing a single source of truth for regulatory data across registrations, submissions, labeling, artwork, intelligence, and change control. It is targeted at pharmaceutical, medical device, and consumer product companies seeking a centralized regulatory data backbone.

2Freyr GRI (Global Regulatory Intelligence)
CategoryRegulatory Intelligence Platform / SaaS
Description

Freyr GRI is an AI-powered regulatory intelligence platform that delivers tailored, data-driven insights for regulatory tracking and strategic decision-making. Powered by AI, NLP, and ML technologies, it serves pharmaceutical, medical device, and consumer product companies needing to monitor and interpret regulatory changes across global markets.

3Via - Variation Identification Agent
CategoryAI Agent / Regulatory Change Management Software
Description

Via is an AI-powered autonomous agent for post-approval change management that identifies variations in regulatory submissions across jurisdictions. It is targeted at pharmaceutical regulatory affairs and operations teams managing complex post-approval change workflows for medicinal products globally.

4Medicinal Products Regulatory Services
CategoryRegulatory Affairs Professional Services
Description

End-to-end regulatory service offering for pharmaceutical and medicinal product companies covering regulatory affairs strategy, dossier authoring, submissions management, regulatory medical writing, pharmacovigilance, medical and scientific communication, compliance/audit/validation, regulatory artwork, and global regulatory intelligence. It is targeted at innovator and generic pharma companies requiring lifecycle regulatory support across global markets.

5Medical Devices Regulatory Services
CategoryMedical Device Regulatory Services
Description

Comprehensive regulatory service offering for medical device and IVD manufacturers spanning Digital Health/SaMD registration, market access, post-market surveillance, EU MDR/IVDR compliance, clinical and performance evaluation, QMS, artwork services, and regulatory affairs. It is targeted at medical device OEMs, SaMD companies, and IVD manufacturers seeking multi-jurisdictional regulatory support.

6Consumer Sector Regulatory Services
CategoryConsumer Products Regulatory Services
Description

Regulatory service offering for consumer product companies in Cosmetics, Food Supplements, and Chemicals. Services include product labeling, safety assessment, global regulatory compliance, formulation review, artwork services, and cosmetovigilance. Targeted at CPG manufacturers expanding into new geographies or responding to evolving regulations such as MoCRA, EUDR, and REACH.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the world's largest CRO and life sciences services firm, offering regulatory affairs and compliance services alongside clinical research, technology, and analytics. It competes with Freyr in pharma regulatory outsourcing and represents the dominant enterprise-scale competitor.

TypeBroad incumbent
Description

Parexel is a top-tier global CRO providing regulatory consulting, submissions management, and clinical services to pharma and medical device companies. It overlaps with Freyr's regulatory affairs and medical writing offerings for large pharma clients.

TypeBroad incumbent
Description

ICON is a major global CRO with regulatory affairs and pharmacovigilance service lines. After the PRA Health Sciences merger, ICON has substantial regulatory outsourcing capabilities directly comparable to Freyr's service portfolio.

TypeBroad incumbent
Description

Labcorp's drug development division offers comprehensive clinical, regulatory, and central lab services to pharma and biopharma. It is a direct competitor in regulatory strategy, submissions, and pharmacovigilance services.

TypeBroad incumbent
Description

Accenture's Life Sciences practice offers regulatory operations, RIM implementation, and pharmacovigilance consulting leveraging technology and global delivery. It competes directly with Freyr on enterprise RIM and regulatory transformation engagements.

TypeBroad incumbent
Description

Deloitte's Life Sciences regulatory practice provides regulatory strategy, quality compliance, and technology-enabled regulatory operations consulting. It targets the same large pharma and medical device clients as Freyr with a consulting-led delivery model.

TypeBroad incumbent
Description

Charles River offers regulatory and safety reporting services alongside its core preclinical and clinical lab offerings. It is a relevant peer particularly in pharmacovigilance and safety reporting — directly competing service lines with Freyr.

TypeBroad incumbent
Description

Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical, commercial, and regulatory consulting. Its regulatory affairs practice directly overlaps with Freyr's pharma regulatory services.

TypeDirect peer
Description

Inotiv (including its Bolt and Boster acquisitions) provides regulatory and medical device consulting services to pharma and medical device clients. It is a more direct niche peer competing in medical device regulatory and quality systems consulting.

TypeDirect peer
Description

ProPharma Group is a regulatory, compliance, and pharmacovigilance consulting firm serving pharma, medical device, and biotech clients. It is one of the most directly comparable specialty regulatory services peers to Freyr in size and service mix.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Freyr Solutions

Life Sciences Regulatory Servicesfreyrsolutions.com

Freyr Solutions is a global regulatory solutions and services provider serving pharmaceutical, medical device, and consumer product companies across 120+ countries with 2,500+ in-house experts and an AI-first regulatory cloud platform (Freya Fusion) covering submissions, labeling, and lifecycle management.

What Freyr Solutions does

Freyr Solutions is a global regulatory solutions and services company founded in 2011 and headquartered in Princeton, USA, with its primary operational hub in Hyderabad, India. The company serves pharmaceutical, medical device, and consumer product companies across 120+ countries, employing 2,500+ in-house regulatory experts and operating through a network of 850+ in-country regulatory affiliates, 20+ global operational centers, and 10 global delivery hubs. Its core offering is Freya Fusion, an AI-first regulatory cloud platform covering the full regulatory information management (RIM) lifecycle — registrations, submissions, labeling, artwork, intelligence, and change control — complemented by specialized AI products including Freya Intelligence (a regulatory-context-trained knowledge retrieval wizard), Via (an autonomous variation identification agent), and Freyr GRI (an AI/NLP/ML-powered global regulatory intelligence platform).

The company's revenue model combines professional services — regulatory affairs strategy, submissions management, pharmacovigilance, regulatory medical writing, and quality/compliance auditing — with subscription-based SaaS offerings on the Freya Fusion platform. Services are sold via direct enterprise sales to large pharmaceutical, medical device, and consumer product manufacturers under multi-year, quote-based contracts. Customer segments are organized vertically, with pharmaceutical/medicinal products and medical device manufacturers as primary, and cosmetics, food/dietary supplements, and chemical products as secondary verticals. Go-to-market is enterprise-led, supported by inside sales and content marketing (whitepapers, webinars, podcasts, and case studies).

In 2024, Freyr was recognized by Everest Group as a Leader in its PEAK Matrix Assessment for Life Sciences Regulatory and Medical Affairs Operations. The company maintains named executive leadership including Co-Founder and Co-CEO Rajiv Rangan, Co-Founder and Chief Risk Officer Srinivas Ranabothu, Co-Founder Srini Sadhu, and CTO Praveen Bezawada. Ownership is private with no disclosed parent, investor, or funding history in the source material.

Freyr Solutions firmographics

Firmographics
Name
Freyr Solutions
Legal name
Freyr Solutions
Website
https://freyrsolutions.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Freyr Solutions is a global regulatory solutions and services provider serving pharmaceutical, medical device, and consumer product companies across 120+ countries with 2,500+ in-house experts and an AI-first regulatory cloud platform (Freya Fusion) covering submissions, labeling, and lifecycle management.
Ownership category
akta.pro rank

Freyr Solutions industry classification

Industry
Product category
Life Sciences Regulatory Services
NAICS
Management, Scientific, and Technical Consulting Services (5416)
SIC
Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYHLAAADAJ
RNA Therapeutics Regulatory, Quality & Pharmacovigilance (GxP, comparability, post-market)
Healthcare & Life Sciences/Biotechnology & Biologics/RNA Therapeutics (mRNA, siRNA, ASO)

Keywords

  • Regulatory affairs services
  • Pharmacovigilance services
  • Medical device compliance
  • Regulatory cloud platform
  • Global regulatory intelligence

Where Freyr Solutions is headquartered

Location

Headquarters

HQ city
Princeton
HQ country
United States
HQ region
North America

Offices11 records

Markets served

Freyr Solutions business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Regulatory Affairs Services: End-to-end regulatory affairs consulting and support including regulatory strategy, submissions management, dossier authoring, and lifecycle management for pharmaceutical, medical device, and consumer product companies.
  2. Pharmacovigilance Services: Drug safety monitoring services including medical literature monitoring, individual case safety reports, aggregate safety reports, signal detection, and risk management plans.
  3. Quality Management and Compliance Services: QMS consultancy, GxP audit services, CSV/CSA services, SOP writing, and regulatory compliance validation for medical devices and pharmaceutical companies.
  4. Regulatory Technology Solutions: SaaS-based regulatory cloud platform (Freya Fusion) with AI capabilities for submissions management, labeling management, regulatory intelligence, and change control.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise pricing based on project scope

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Freyr Solutions product offering

Product offering

Core offering

Freyr Solutions delivers end-to-end regulatory solutions and services for pharmaceutical, medical device, and consumer product companies across 120+ countries. The core offering combines professional services (regulatory affairs, regulatory operations, medical writing, pharmacovigilance, quality/compliance, artwork) with the AI-first Freya Fusion regulatory cloud platform covering RIM, submissions, labeling, artwork, intelligence, and change control. Freyr supports large, medium, and small life sciences firms with 2,500+ in-house regulatory experts and localized affiliate support.

Product overview

Freyr Solutions is the largest global Regulatory solutions and services provider offering end-to-end solutions to the Pharmaceutical (Medicinal Products), Medical Devices, and Consumer sectors. The portfolio consists of the core AI-first technology platform Freya Fusion (unified regulatory cloud covering RIM, submissions, labeling, artwork, intelligence, and change control) supported by specialized sub-products including Freya Intelligence (AI-enabled regulatory advisor with knowledge retrieval), Via (Variation Identification Agent for autonomous post-approval change management), and Freyr GRI (AI/NLP/ML-powered global regulatory intelligence). Services span Regulatory Affairs, Regulatory Operations, Regulatory Medical Writing, Pharmacovigilance, Quality Management, Medical Writing for Medical Devices, Performance Evaluation (IVD), Literature Search Protocol, and Compliance/Audit services across 120+ countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Freya Fusion: AI-First Regulatory Cloud - unified regulatory platform designed to manage entire regulatory lifecycle and be the single source of truth for data. Streamlines processes, ensures compliance, and accelerates time-to-market with intelligent automation and connected workflows.
  • Freyr GRI
  • Freya
  • Via (Variation Identification Agent)

Products and services

  • Freya Fusion Freya Fusion is an AI-first regulatory cloud platform built on 15+ years of regulatory expertise and advanced AI/ML capabilities. It serves as a unified ecosystem for RIM (Regulatory Information Management), providing a single source of truth for regulatory data across registrations, submissions, labeling, artwork, intelligence, and change control. It is targeted at pharmaceutical, medical device, and consumer product companies seeking a centralized regulatory data backbone.
  • Freyr GRI (Global Regulatory Intelligence) Freyr GRI is an AI-powered regulatory intelligence platform that delivers tailored, data-driven insights for regulatory tracking and strategic decision-making. Powered by AI, NLP, and ML technologies, it serves pharmaceutical, medical device, and consumer product companies needing to monitor and interpret regulatory changes across global markets.
  • Via - Variation Identification Agent Via is an AI-powered autonomous agent for post-approval change management that identifies variations in regulatory submissions across jurisdictions. It is targeted at pharmaceutical regulatory affairs and operations teams managing complex post-approval change workflows for medicinal products globally.
  • Medicinal Products Regulatory Services End-to-end regulatory service offering for pharmaceutical and medicinal product companies covering regulatory affairs strategy, dossier authoring, submissions management, regulatory medical writing, pharmacovigilance, medical and scientific communication, compliance/audit/validation, regulatory artwork, and global regulatory intelligence. It is targeted at innovator and generic pharma companies requiring lifecycle regulatory support across global markets.
  • Medical Devices Regulatory Services Comprehensive regulatory service offering for medical device and IVD manufacturers spanning Digital Health/SaMD registration, market access, post-market surveillance, EU MDR/IVDR compliance, clinical and performance evaluation, QMS, artwork services, and regulatory affairs. It is targeted at medical device OEMs, SaMD companies, and IVD manufacturers seeking multi-jurisdictional regulatory support.
  • Consumer Sector Regulatory Services Regulatory service offering for consumer product companies in Cosmetics, Food Supplements, and Chemicals. Services include product labeling, safety assessment, global regulatory compliance, formulation review, artwork services, and cosmetovigilance. Targeted at CPG manufacturers expanding into new geographies or responding to evolving regulations such as MoCRA, EUDR, and REACH.

Quantifiable outcome

  • Zero rejections achieved for pharmaceutical company managing 15+ ANDAs/NDAs
  • +2 more outcomes

Companies that use Freyr Solutions

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles3 records

Freyr Solutions technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Freyr Solutions partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Freyr Solutions competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the world's largest CRO and life sciences services firm, offering regulatory affairs and compliance services alongside clinical research, technology, and analytics. It competes with Freyr in pharma regulatory outsourcing and represents the dominant enterprise-scale competitor.
  • Parexel International: Parexel is a top-tier global CRO providing regulatory consulting, submissions management, and clinical services to pharma and medical device companies. It overlaps with Freyr's regulatory affairs and medical writing offerings for large pharma clients.
  • ICON plc: ICON is a major global CRO with regulatory affairs and pharmacovigilance service lines. After the PRA Health Sciences merger, ICON has substantial regulatory outsourcing capabilities directly comparable to Freyr's service portfolio.
  • Labcorp Drug Development (formerly Covance): Labcorp's drug development division offers comprehensive clinical, regulatory, and central lab services to pharma and biopharma. It is a direct competitor in regulatory strategy, submissions, and pharmacovigilance services.
  • Accenture Life Sciences: Accenture's Life Sciences practice offers regulatory operations, RIM implementation, and pharmacovigilance consulting leveraging technology and global delivery. It competes directly with Freyr on enterprise RIM and regulatory transformation engagements.
  • Deloitte Life Sciences Regulatory: Deloitte's Life Sciences regulatory practice provides regulatory strategy, quality compliance, and technology-enabled regulatory operations consulting. It targets the same large pharma and medical device clients as Freyr with a consulting-led delivery model.
  • Charles River Laboratories: Charles River offers regulatory and safety reporting services alongside its core preclinical and clinical lab offerings. It is a relevant peer particularly in pharmacovigilance and safety reporting — directly competing service lines with Freyr.
  • Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical, commercial, and regulatory consulting. Its regulatory affairs practice directly overlaps with Freyr's pharma regulatory services.

Direct peers

  • Inotiv (regulatory and medical device services): Inotiv (including its Bolt and Boster acquisitions) provides regulatory and medical device consulting services to pharma and medical device clients. It is a more direct niche peer competing in medical device regulatory and quality systems consulting.
  • ProPharma Group: ProPharma Group is a regulatory, compliance, and pharmacovigilance consulting firm serving pharma, medical device, and biotech clients. It is one of the most directly comparable specialty regulatory services peers to Freyr in size and service mix.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Freyr Solutions social profiles

Digital presence

Freyr Solutions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Freyr Solutions leadership team

Management profile

Number of profiles

Profiles6 records

Freyr Solutions funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Freyr Solutions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Freyr Solutions

What does Freyr Solutions do?

Freyr Solutions delivers end-to-end regulatory solutions and services for pharmaceutical, medical device, and consumer product companies across 120+ countries. The core offering combines professional services (regulatory affairs, regulatory operations, medical writing, pharmacovigilance, quality/compliance, artwork) with the AI-first Freya Fusion regulatory cloud platform covering RIM, submissions, labeling, artwork, intelligence, and change control. Freyr supports large, medium, and small life sciences firms with 2,500+ in-house regulatory experts and localized affiliate support.

Is Freyr Solutions a public or private company?

Freyr Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Freyr Solutions founded?

Freyr Solutions was founded in 2011. It employs 1,001 to 5,000 people.

Where is Freyr Solutions based?

Freyr Solutions is headquartered in Princeton, United States, in the North America region.

How does Freyr Solutions make money?

Four revenue lines are on record. Regulatory Affairs Services are the primary driver. The others are pharmacovigilance Services, quality Management and Compliance Services and regulatory Technology Solutions.

Who are Freyr Solutions's main competitors?

Broad incumbents on record are IQVIA, Parexel International, ICON plc, Labcorp Drug Development (formerly Covance), Accenture Life Sciences, Deloitte Life Sciences Regulatory, Charles River Laboratories and Syneos Health. Direct peers are Inotiv (regulatory and medical device services) and ProPharma Group.

Does Freyr Solutions have an API?

No public API is recorded for Freyr Solutions.

What industry is Freyr Solutions in?

Freyr Solutions's product category is Life Sciences Regulatory Services. Its primary akta.pro industry code is HLAAADAJ, RNA Therapeutics Regulatory, Quality & Pharmacovigilance (GxP, comparability, post-market). Its NAICS code is 5416 and its SIC code is 8700.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMedical Writing Market Covering Prime Factors and Competitive Outlook till 2026 || Freyr Solutions, Nucleus Global, Indegene, ICONVerified Market Research published a market analysis report on the global Medical Writing sector, projecting growth driven by increasing clinical trial activity and stricter regulatory documentation requirements. The study identifies key industry players including IQVIA, Parexel, Syneos Health, ICON, Indegene, Freyr Solutions, and Nucleus Global as major contributors to the competitive landscape.GlobeNewswireNorth America Medical Writing Market Analysis Report 2025-2033 | Expanding Pharma–Biotech R&D, Rising Regulatory Complexity, and Increasing Demand for Scientific CommunicationResearch and Markets published a report forecasting the North America medical writing market to grow from $1.76 billion in 2024 to $4.23 billion by 2033, driven by increased pharmaceutical R&D and regulatory complexity. The analysis highlights key industry participants including Parexel, Freyr, and Labcorp Drug Development as major players benefiting from this expansion.YahooNorth America Medical Writing Market Analysis Report 2025-2033 | Expanding Pharma–Biotech R&D, Rising Regulatory Complexity, and Increasing Demand for Scientific CommunicationResearchAndMarkets.com has added a market analysis report projecting the North American medical writing market to grow from $1.76 billion in 2024 to $4.23 billion by 2033, driven by increasing pharmaceutical R&D and regulatory complexity. Key industry participants identified in the report include Parexel, Freyr, Labcorp Drug Development, and others who provide essential documentation services for clinical trials and regulatory submissions.EIN PresswireMedical Writing Market to Reach USD 10.67 Billion by 2032 | Size, Share, Trends, Forecast, Demand & Competitive AnalysisThe global medical writing market is expanding rapidly, driven by adoption of AI tools, natural language processing, and real-world evidence integration, focusing on clinical, regulatory, and scientific communication. Major regions include North America and Europe, with key contributions from companies like Trilogy Writing and Freyr; the market is expected to reach USD 10.67 billion by 2032.Global Regulatory Solutions and Services CompanyGMP Regulations ExplainedGood Manufacturing Practice (GMP) regulations are a set of guidelines designed to ensure the consistent production of high-quality, safe, and pure pharmaceuticals. These standards cover the entire manufacturing process from raw material sourcing to final packaging and are enforced by regulatory bodies such as the FDA and EMA. The article serves as an informational overview of these principles and promotes Freyr's regulatory consulting services.openPR.comEnd-to-End Regulatory Lifecycle Management SoftwareFreyr announced the launch of Freya Fusion, its AI-first regulatory cloud platform, on July 1, 2025. The platform unifies regulatory workflows, automates tasks, and includes a conversational assistant, with a new website at freyafusion.com. The company covers 3,600 regulatory requirements across medicinal products, devices, and chemicals.Global Regulatory Solutions and Services CompanyThe Future of PharmacovigilanceThe article discusses the transformation of pharmacovigilance through the integration of AI, machine learning, and big data analytics to enhance real-time safety monitoring and signal detection. It highlights evolving regulatory frameworks from agencies like the FDA and EMA that address these technological shifts while emphasizing a more patient-centric approach to drug safety. The piece concludes by promoting Freyr Solutions as a regulatory partner capable of helping life sciences companies navigate these complex changes.openPR.comGlobal Medical Device Complaint Handling Software Market Size, Share and Forecast By Key Players-MasterControl,Parexel International Corporation,SAS,Freyr,AssurXThe global medical device complaint handling software market is projected to grow from $15.54 billion in 2024 to $23.41 billion by 2031, a CAGR of 7.07%. Growth is driven by regulatory compliance, patient safety, and digital health adoption, with Asia-Pacific expected to be the fastest-growing region.Global Regulatory Solutions and Services CompanyUnderstanding Pet Care Product Registration: A Complete GuideA blog post outlines the regulatory requirements for pet care products, covering categories such as grooming aids, attire, toys, food, supplements and medical care items. It details oversight by the U.S. FDA, EPA and CPSC, Canada's CCPSA, EU GPSR and REACH, and Australia's APVMA, plus labelling, safety assessments, advertising claims and pre-market approval. The article promotes Freyr's regulatory services.